TKPHF Comptes : Analyse IA Takeda Pharmaceutical Company Limited

Accueil

Stock

TKPHF

TKPHF Financier

Takeda Pharmaceutical Company Limited

$39.2

13.98%

$4.81

À la fermeture : Feb 13, 16:00:00 GMT-5

$39.2

Post-Marché: Feb 13, 20:00:00 GMT-5

Aperçu Prévision Gagner Dividendes Comptes financiers

Revenus

État de situation

Flux de trésorerie

Annuel

Trimestriellement

TKPHF Revenu

Chiffres en millions de dollars américains. L'exercice financier va de février à janvier.

Breakdown	TTM	03/31/2025	03/31/2024	03/31/2023	03/31/2022	03/31/2021
Revenus	4,464,578	4,581,551	4,263,762	4,027,478	3,569,006	3,197,812
Croissance des revenus (H/H)	-3%	7%	6%	13%	12%	-3%
Coût des ventes	1,547,962	1,580,217	1,426,678	1,244,072	1,106,846	994,308
Bénéfice brut	2,916,616	3,001,334	2,837,084	2,783,406	2,462,160	2,203,504
Vente, Général et Administration	1,088,085	1,104,766	1,053,819	997,309	886,361	875,663
Recherche et développement	696,611	730,227	729,924	633,325	526,087	455,833
Frais d'exploitation	2,436,102	2,464,303	2,406,297	2,232,511	1,916,672	1,867,782
Autres revenus (charges) non opérationnels	--	0	1	--	1	--
Bénéfice avant impôts	205,369	175,084	52,791	375,090	302,571	366,235
Charge d'impôt sur le revenu	92,184	66,941	-91,406	58,052	72,405	-9,936
Bénéfice net	112,926	107,928	144,067	317,017	230,059	376,005
Croissance du bénéfice net	-46%	-25%	-55%	38%	-39%	750%
Actions en circulation (diluées)	1,578.74	1,578.87	1,564.45	1,569.87	1,577.16	1,573.53
Variation des actions (H-H)	0%	1%	0%	0%	0%	0%
EPS (dilué)	71.52	68.35	92.08	201.93	145.86	238.95
Croissance du EPS	-46%	-26%	-54%	38%	-39%	746%
Flux de trésorerie libre	748,694	709,341	235,614	343,467	937,068	774,463
Flux de trésorerie libre par action	--	--	--	--	--	--
Marge brute	65.32%	65.5%	66.53%	69.11%	68.98%	68.9%
Marge opérationnelle	10.76%	11.72%	10.1%	13.67%	15.28%	10.49%
Marge bénéficiaire	2.52%	2.35%	3.37%	7.87%	6.44%	11.75%
Marge du flux de trésorerie libre	16.76%	15.48%	5.52%	8.52%	26.25%	24.21%
EBITDA	1,227,540	1,298,427	1,158,789	1,215,295	1,128,639	895,393
Marge EBITDA	27.49%	28.34%	27.17%	30.17%	31.62%	28%
D&A pour le résultat opérationnel	747,026	761,396	728,002	664,400	583,151	559,671
EBIT	480,514	537,031	430,787	550,895	545,488	335,722
Marge EBIT	10.76%	11.72%	10.1%	13.67%	15.28%	10.49%
Taux d'imposition effectif	44.88%	38.23%	-173.14%	15.47%	23.92%	-2.71%

Statistiques clés

Clôture préc.

$34.39

Prix d'ouverture

$39.2

Plage de la journée

$39.2 - $39.2

Plage de 52 semaines

$24.95 - $39.2

Volume

253

Volume moyen

27.0K

BPA (TTM)

0.13

Rendement en dividend

Capitalisation boursière

$61.9B

Qu’est-ce que Takeda Pharmaceutical Co., Ltd. ?

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 47,455 full-time employees. The firm focuses on the main business areas of gastrointestinal diseases, rare diseases, plasma derivatives (immune diseases), oncology (cancer), and neuroscience (neuropsychiatric diseases). The firm focuses on three research and development areas: innovative biopharmaceuticals with the focus on gastrointestinal and inflammatory diseases, neuroscience, and oncology, plus plasma derivatives and vaccines. Most of the pharmaceuticals treat rare diseases in the focus disease areas and the plasma derivatives area. The firm operates in Japan, the United States, Europe, and China.



Fonctionnalités

Copilote IA pour actions et cryptomonnaies

Prédiction des prix

Suivi des collectes de fonds

Thèmes

Comparaison de cryptomonnaies

Ressources